Jefferies downgraded Horizon Therapeutics (HZNP) to Hold from Buy after Amgen (AMGN) and Horizon announced the entry into a consent order agreement that resolves the pending FTC administrative lawsuit and “clears the path to take the final steps to close Amgen’s acquisition of Horizon.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HZNP:
- Horizon Therapeutics (NASDAQ:HZNP) Gains after FTC Settlement
- Amgen, Horizon enter consent order agreement with FTC to close acquisition
- AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
- Amgen, Horizon Therapeutics confirm resolution of FTC lawsuit
- Amgen to settle FTC and state challenges to Horizon Therapeutics takeover
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue